Literature DB >> 30051493

Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.

Balabhadrapatruni V S K Chakravarthi1,2, Darshan S Chandrashekar1,2, Sai Akshaya Hodigere Balasubramanya1,2, Alyncia D Robinson1, Shannon Carskadon3, Uttam Rao4, Jennifer Gordetsky1,2, Upender Manne1,2, George J Netto1,2, Sunil Sudarshan2,5, Nallasivam Palanisamy3, Sooryanarayana Varambally1,2.   

Abstract

Prostate cancer (PCa) is one of the most frequently diagnosed cancers among men. Many molecular changes have been detailed during PCa progression. The gene encoding the transcription factor ERG shows recurrent rearrangement, resulting in the overexpression of ERG in the majority of prostate cancers. Overexpression of ERG plays a critical role in prostate oncogenesis and development of metastatic disease. Among the downstream effectors of ERG, Frizzled family member FZD4 has been shown to be a target of ERG. Frizzled-8 (FZD8) has been shown to be involved in PCa bone metastasis. In the present study, we show that the expression of FZD8 is directly correlated with ERG expression in PCa. Furthermore, we show that ERG directly targets and activates FZD8 by binding to its promoter. This activation is specific to ETS transcription factor ERG and not ETV1. We propose that ERG overexpression in PCa leads to induction of Frizzled family member FZD8, which is known to activate the Wnt pathway. Taken together, these findings uncover a novel mechanism for PCa metastasis, and indicate that FZD8 may represent a potential therapeutic target for PCa.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ERG; Frizzled 8; Wnt signaling; metastasis; prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 30051493     DOI: 10.1002/pros.23704

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

Review 1.  Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.

Authors:  Lu Yao; Xiangyu Zhang
Journal:  J Cancer       Date:  2022-06-13       Impact factor: 4.478

Review 2.  The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer.

Authors:  Ealia Khosh Kish; Muhammad Choudhry; Yaser Gamallat; Sabrina Marsha Buharideen; Dhananjaya D; Tarek A Bismar
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.

Authors:  Sean Porazinski; Michael Ladomery; Ling Li; Lisa Hobson; Laura Perry; Bethany Clark; Susan Heavey; Aiman Haider; Ashwin Sridhar; Greg Shaw; John Kelly; Alex Freeman; Ian Wilson; Hayley Whitaker; Elmar Nurmemmedov; Sebastian Oltean
Journal:  Br J Cancer       Date:  2020-06-25       Impact factor: 7.640

Review 4.  Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis.

Authors:  Shian-Ren Lin; Ntlotlang Mokgautsi; Yen-Nien Liu
Journal:  Molecules       Date:  2020-05-20       Impact factor: 4.411

5.  Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian Cancer.

Authors:  S Udhaya Kumar; D Thirumal Kumar; R Siva; C George Priya Doss; Hatem Zayed
Journal:  Front Bioeng Biotechnol       Date:  2019-12-17

6.  Cyclic Stretch Induces Vascular Smooth Muscle Cells to Secrete Connective Tissue Growth Factor and Promote Endothelial Progenitor Cell Differentiation and Angiogenesis.

Authors:  Jing Yan; Wen-Bin Wang; Yang-Jing Fan; Han Bao; Na Li; Qing-Ping Yao; Yun-Long Huo; Zong-Lai Jiang; Ying-Xin Qi; Yue Han
Journal:  Front Cell Dev Biol       Date:  2020-12-09

Review 7.  Wnt/β-catenin signaling in cancers and targeted therapies.

Authors:  Fanyuan Yu; Changhao Yu; Feifei Li; Yanqin Zuo; Yitian Wang; Lin Yao; Chenzhou Wu; Chenglin Wang; Ling Ye
Journal:  Signal Transduct Target Ther       Date:  2021-08-30

8.  Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.

Authors:  Yang Li; Zirong Liu; Yamin Zhang
Journal:  BMC Gastroenterol       Date:  2021-02-22       Impact factor: 3.067

9.  Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.

Authors:  Christian Bernreuther; Ferdous Daghigh; Katharina Möller; Claudia Hube-Magg; Maximilian Lennartz; Florian Lutz; Sebastian Dwertmann Rico; Christoph Fraune; David Dum; Andreas M Luebke; Till Eichenauer; Christina Möller-Koop; Thorsten Schlomm; Corinna Wittmer; Hartwig Huland; Hans Heinzer; Markus Graefen; Alexander Haese; Eike Burandt; Maria Christina Tsourlakis; Till S Clauditz; Doris Höflmayer; Jakob R Izbicki; Ronald Simon; Guido Sauter; Sarah Minner; Stefan Steurer; Jan Meiners
Journal:  Pathol Oncol Res       Date:  2020-07-16       Impact factor: 3.201

10.  Sorting Nexin 27 as a potential target in G protein‑coupled receptor recycling for cancer therapy (Review).

Authors:  Zixu Bao; Shijun Zhou; Haisheng Zhou
Journal:  Oncol Rep       Date:  2020-09-14       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.